The Therapeutic Value of Monoclonal Antibodies Directed Against Immunogenic Tumor Glycoproteins

Monoclonal antibodies developed against immunogenic proteins (Tumor Specific Antigens/TSA's) that are expressed in human cancers, display a unique behavioral pattern. They appear to serve in a dual role. This includes the early recognition of these immunogenic membrane proteins that can serve a...

Descripción completa

Detalles Bibliográficos
Autores principales: Arlen, Myron, Arlen, Philip, Tsang, Al, Wang, XuePing, Gupta, Rishab
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974238/
https://www.ncbi.nlm.nih.gov/pubmed/21060731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974238/
https://www.ncbi.nlm.nih.gov/pubmed/21060731

Ejemplares similares